BRDXCOACNOR8
BRDXCOACNOR8
DEXCO ON NM
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 6.95B EUR | 4.51B EUR | 4.28B EUR | 4.54B EUR |
Enterprise Value | 13.29B EUR | 8.12B EUR | 6.97B EUR | 10.84B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | 13.84x | -- | -- | -- |
Price to Sales | 0.82x | 0.71x | 0.69x | 0.74x |
Price to Book | 1x | 0.65x | 0.62x | 0.66x |
EV/Revenue | 1.57x | 1.28x | 1.12x | 1.77x |
EV/EBITDA | 7.01x | 4.22x | 3.68x | 6.27x |
Price to FCF (P/FCF) | 685.03x | 13.12x | 12.96x | -- |
EV/FCF | 1,308.88x | 23.6x | 21.11x | -- |
FCF Yield | 0.15% | 7.62% | 7.72% | -2.99% |